Chlamydia pneumoniae Infection and Inflammatory Diseases
- PMID: 30687565
- PMCID: PMC6345537
- DOI: 10.1615/ForumImmunDisTher.2017020161
Chlamydia pneumoniae Infection and Inflammatory Diseases
Abstract
Chlamydia pneumoniae, an obligate intracellular bacterial pathogen, has long been investigated as a potential developmental or exacerbating factor in various pathologies. Its unique lifestyle and ability to disseminate throughout the host while persisting in relative safety from the immune response has placed this obligate intracellular pathogen in the crosshairs as a potentially mitigating factor in chronic inflammatory diseases. Many animal model and human correlative studies have been performed to confirm or deny a role for C. pneumoniae infection in these disorders. In some cases, antibiotic clinical trials were conducted to prove a link between bacterial infections and atherosclerosis. In this review, we detail the latest information regarding the potential role that C. pneumoniae infection may have in chronic inflammatory diseases.
Keywords: Alzheimer’s; Chlamydia pneumoniae; arthritis; asthma; atherosclerosis; cancer.
Figures
References
-
- Yang ZP, Kuo CC, Grayston JT. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice. J Infect Dis. 1995;171(3):736–8. - PubMed
-
- Rottenberg ME, Gigliotti Rothfuchs AC, Gigliotti D, Svanholm C, Bandholtz L, Wigzell H. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J Immunol. 1999;162(5):2829–36. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources